Product Information
18114-1-AP targets BCL2L10 in WB, IF, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag12596 Product name: Recombinant human BCL2L10 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-172 aa of BC093826 Sequence: MVDQLRERTTMADPLRERTELLLADYLGYCAREPGTPEPAPSTPEAAVLRSAAARLRQIHRSFFSAYLGYPGNRFELVALMADSVLSDSPGPTWGRVVTLVTFAGTLLERGPLVTARWKKWGFQPRLKEQEGDVARDCQRLVALLSSRLMGQHRAWLQAQGGWDGFCHFFRT Predict reactive species |
| Full Name | BCL2-like 10 (apoptosis facilitator) |
| Calculated Molecular Weight | 204 aa, 23 kDa |
| Observed Molecular Weight | 22 kDa |
| GenBank Accession Number | BC093826 |
| Gene Symbol | BCL2L10 |
| Gene ID (NCBI) | 10017 |
| RRID | AB_10640581 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9HD36 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Publications
What published studies show
The BCL2L10 Polyclonal antibody (Cat# 18114-1-AP) has 1 citation. It appears in Molecular Oncology (IF 4.5), in a study investigating UBQLN4 as an ATM substrate that stabilizes anti-apoptotic proteins BCL2A1 and BCL2L10 in mesothelioma. The research field encompasses mesothelioma biology, apoptosis regulation, and ATM signaling pathways. The antibody was applied in WB, IP, and IF for human samples.
| Species | Application | Title |
|---|---|---|
Mol Oncol UBQLN4 is an ATM substrate that stabilizes the anti-apoptotic proteins BCL2A1 and BCL2L10 in mesothelioma. |
